Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement

被引:4
作者
Fen, Xinglai [1 ]
Qin, Weifeng [1 ]
Bao, Wuan [1 ]
Jiang, Feng [1 ]
Li, Bin [1 ]
Hu, Fujun [1 ]
Chen, Xiaozhong [1 ]
机构
[1] Zhejiang Canc Hosp, Radiat Therapy Dept Oncol, Hangzhou 310022, Zhejiang, Peoples R China
关键词
nasopharyngeal carcinoma; comprehensive treatment; interventional chemotherapy; intensity modulated radiation therapy; RADIOTHERAPY; EXPERIENCE; CANCER;
D O I
10.3892/ol.2013.1407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to ensure a high dose of intensity modulated radiation therapy (IMRT) was delivered to tumor tissue with a low dose to normal organs. Seldinger interventional techniques were used to inject chemotherapy drugs for nasopharyngeal carcinoma (NPC). IMRT was conducted 3 weeks after intervention. Primary tumor volume was reduced by 42.76% after 2 doses of interventional chemotherapy and intracranial tumor volume was reduced by 55.63%. All patients presented grade II and above nasopharyngeal mucositis. In the 2 years following radiotherapy, overall survival (OS) was 83.3% and progression-free survival (PFS) was 75%. In conclusion, T4 NPC patients with intracranial extension received induction chemotherapy followed by IMRT and concurrent chemotherapy, which proved to be efficacious and well tolerated.
引用
收藏
页码:427 / 431
页数:5
相关论文
共 14 条
[1]   Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population [J].
Airoldi, Mario ;
Gabriele, Anna Maria ;
Garzaro, Massimiliano ;
Raimondo, Luca ;
Condello, Cecilia ;
Beatrice, Fabio ;
Pecorari, Giancarlo ;
Giordano, Carlo .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (01) :105-110
[2]   Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].
Al-Sarraf, M ;
LeBlanc, M ;
Giri, PGS ;
Fu, KK ;
Cooper, J ;
Vuong, T ;
Forastiere, AA ;
Adams, G ;
Sakr, WA ;
Schuller, DE ;
Ensley, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317
[3]  
Al-Sarraf M., 2001, P AM SOC CLIN ONCOL, V20, p227a
[4]   Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients [J].
Baujat, B ;
Audry, W ;
Bourhis, J ;
Chan, ATC ;
Onat, H ;
Chua, DTT ;
Kwong, DLW ;
al-Sarraf, M ;
Chi, KH ;
Hareyama, M ;
Leung, SF ;
Thephamongkhol, K ;
Pignon, JP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01) :47-56
[5]   Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Chan, A. T. C. ;
Felip, E. .
ANNALS OF ONCOLOGY, 2009, 20 :123-125
[6]  
Hu F, 2010, ZHEJIANG MED J, V36, P836
[7]   Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma [J].
Hui, Edwin P. ;
Ma, Brigette B. ;
Leung, Sing F. ;
King, Ann D. ;
Mo, Frankie ;
Kam, Michael K. ;
Yu, Brian K. ;
Chiu, Samuel K. ;
Kwan, Wing H. ;
Ho, Rosalie ;
Chan, Iris ;
Ahuja, Anil T. ;
Zee, Benny C. ;
Chan, Anthony T. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) :242-249
[8]   Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience [J].
Kam, MKM ;
Teo, PML ;
Chau, RMC ;
Cheung, KY ;
Choi, PHK ;
Kwan, WH ;
Leung, SF ;
Zee, B ;
Chan, ATC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05) :1440-1450
[9]  
Lu T, 2004, ZHONGHUA ZHONG LIU S, V60, P508
[10]  
Meng ZW, 2000, LIN CHUANG ER BI YAN, V14, P35